Jointown Pharmaceutical Group Co Ltd
SSE:600998

Watchlist Manager
Jointown Pharmaceutical Group Co Ltd Logo
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Watchlist
Price: 5.53 CNY -2.12% Market Closed
Market Cap: 27.9B CNY
Have any thoughts about
Jointown Pharmaceutical Group Co Ltd?
Write Note

Jointown Pharmaceutical Group Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jointown Pharmaceutical Group Co Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
1099
601607
C
600511
000963
Q
301015

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Cash & Cash Equivalents
ÂĄ7.9B
CAGR 3-Years
-14%
CAGR 5-Years
-3%
CAGR 10-Years
11%
Sinopharm Group Co Ltd
HKEX:1099
Cash & Cash Equivalents
ÂĄ34.4B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
11%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Cash & Cash Equivalents
ÂĄ27.5B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
9%
C
China National Medicines Corp Ltd
SSE:600511
Cash & Cash Equivalents
ÂĄ8.5B
CAGR 3-Years
8%
CAGR 5-Years
13%
CAGR 10-Years
26%
Huadong Medicine Co Ltd
SZSE:000963
Cash & Cash Equivalents
ÂĄ5.4B
CAGR 3-Years
19%
CAGR 5-Years
18%
CAGR 10-Years
16%
Q
Qingdao Baheal Medical Inc
SZSE:301015
Cash & Cash Equivalents
ÂĄ984.6m
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
N/A

See Also

What is Jointown Pharmaceutical Group Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
7.9B CNY

Based on the financial report for Jun 30, 2024, Jointown Pharmaceutical Group Co Ltd's Cash & Cash Equivalents amounts to 7.9B CNY.

What is Jointown Pharmaceutical Group Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
11%

Over the last year, the Cash & Cash Equivalents growth was 17%. The average annual Cash & Cash Equivalents growth rates for Jointown Pharmaceutical Group Co Ltd have been -14% over the past three years , -3% over the past five years , and 11% over the past ten years .

Back to Top